Document is current
Any future updates will be listed below
-
Authors
Usman, Taofeek O.
Adeyanju, Oluwaseun A.
Areola, Emmanuel D.
Badmus, Olufunto O.
Oyeyipo, Ibukun P.
Olaniyi, Kehinde S.
Oyabambi, Adewumi O.
Olatunji, Lawrence A. https://orcid.org/0000-0002-1036-0662
-
Funding
Funding for this research was provided by:
International Society of Hypertension
Association of African Universities (AAU/2017/2018)
- License Information
-
More Information
Article History
Received: 10 May 2020
Accepted: 22 December 2020
First Online: 21 January 2021
Compliance with ethical standards
:
: LAO received eplerenone (PF-02845980) used in this study from Pfizer Inc. (NY, USA) via the Compound Transfer Program (CTP). TOU, OAA, EDA, OOB, IPO, KSO and AOO do not have any conflicts of interest to declare.
: All authors gave consent for this manuscript to be published.
: This study protocol was approved by the University Ethical Review Committee (UERC), University of Ilorin, Ilorin.
